UFP Technologies, Inc. (UFPT)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$288.79+0.79%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · UFPT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 631.6 | 602.8 | 504.4 | 400.1 | 353.8 | 206.3 | 179.4 | 198.4 | 190.5 | 147.8 | 146.1 | 138.9 | 139.3 | 139.2 | 131.0 | 127.2 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 147.8 | 146.1 | 138.9 | 139.3 | 139.2 | 131.0 | 127.2 |
| Cost of Revenues | 451.6 | 432.4 | 357.7 | 287.8 | 263.5 | 155.2 | 134.7 | 144.4 | 142.1 | — | — | — | — | — | — | — |
| Gross Profit | 180.0 | 170.4 | 146.7 | 112.2 | 90.3 | 51.1 | 44.7 | 54.0 | 48.3 | 35.5 | 34.7 | 37.5 | 36.9 | 41.0 | 38.3 | 36.2 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 83.8 | 77.4 | 62.2 | 50.9 | 45.8 | 29.5 | 27.5 | 29.3 | 27.7 | 23.7 | 24.1 | 24.0 | 23.8 | 23.6 | 21.7 | 21.4 |
| R&D Expenses | — | 8.6 | 10.4 | 7.2 | 9.3 | 8.5 | 8.2 | 8.8 | — | 5.0 | 1.3 | 1.3 | 1.4 | 1.2 | 1.3 | — |
| Operating Income | 96.3 | 92.3 | 80.9 | 57.7 | 55.4 | 21.2 | 16.7 | 24.7 | 19.6 | 11.7 | 12.2 | 11.7 | 11.6 | 17.4 | 16.7 | 15.7 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 9.8 | 8.1 | 3.6 | 2.8 | 0.0 | 0.1 | 0.7 | 1.3 | 0.1 | 0.1 | — | — | — | — | — |
| Interest & Investment Income | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | — | — | — | — | — |
| Net Interest Expenses | — | — | — | — | — | (0.0) | 0.1 | 0.7 | 1.3 | (0.2) | (0.1) | — | — | — | — | — |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | 0.2 | 0.1 | 0.0 | 0.2 | (0.2) | (0.1) | (0.0) |
| EBT, Incl. Unusual Items | 88.6 | 82.5 | 73.0 | 53.9 | 52.7 | 21.2 | 16.3 | 23.6 | 18.4 | 11.9 | 12.3 | 11.7 | 11.8 | 17.2 | 16.6 | 15.7 |
| Income Tax Expense | 16.3 | 14.2 | 14.0 | 9.0 | 10.9 | 5.3 | 2.9 | 3.9 | 4.1 | 2.6 | 4.3 | 4.1 | 4.2 | 5.9 | 5.7 | 4.9 |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.4 | 0.4 | 0.4 |
| Net Income | 72.3 | 68.3 | 59.0 | 44.9 | 41.8 | 15.9 | 13.4 | 19.8 | 14.3 | 9.2 | 8.0 | 7.6 | 7.6 | 11.3 | 10.9 | 10.8 |
| Per Share | ||||||||||||||||
| Basic EPS | 9.34 | 8.87 | 7.69 | 5.89 | 5.52 | 2.11 | 1.79 | 2.66 | 1.95 | 1.27 | 1.11 | 1.07 | 1.08 | 1.65 | 1.63 | 1.60 |
| Diluted EPS | 9.28 | 8.75 | 7.58 | 5.83 | 5.45 | 2.09 | 1.77 | 2.63 | 1.93 | 1.26 | 1.10 | 1.05 | 1.05 | 1.59 | 1.55 | 1.48 |
| Revenue per Share | 81.10 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 7.7 | 7.7 | 7.7 | 7.6 | 7.6 | 7.5 | 7.5 | 7.4 | 7.3 | 7.2 | 7.2 | 7.1 | 7.0 | 6.8 | 6.7 | 6.5 |
| Diluted Weighted Avg Shares | 7.8 | 7.8 | 7.8 | 7.7 | 7.7 | 7.6 | 7.6 | 7.5 | 7.4 | 7.3 | 7.3 | 7.2 | 7.2 | 7.1 | 7.0 | 7.0 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 101.7 | 88.9 | 64.7 | 62.9 | 28.3 | 23.7 | 31.6 | 26.2 | 17.0 | 17.5 | 16.2 | 15.6 | 21.0 | 19.5 | 18.5 |
| EBIT | 96.3 | 92.3 | 80.9 | 57.7 | 55.4 | 21.2 | 16.7 | 24.7 | 19.6 | 11.7 | 12.2 | 11.7 | 11.6 | 17.4 | 16.7 | 15.7 |
| Effective Tax Rate | 18.4% | — | — | 16.7% | 20.7% | 25.1% | 17.9% | 16.5% | 22.2% | 22.3% | 35.3% | 35.3% | 35.8% | 34.4% | 34.3% | 31.3% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.